Nitrite-free bacon sales boom in UK amid fears over curing chemicals — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Denhay launched two nitrite-free back bacon lines (smoked and unsmoked, 200g, £4 each) in 570 Tesco stores from 21 September, with managing director Marlene Godwin saying the move was prompted by retailers and shoppers, not producer advocacy: 'This is about giving bacon lovers choice, not replacement.'
- Waitrose doubled its Made Without Nitrites range in the past year, with sales up more than 34%; its British roast and honey roast hams rose more than 70% since launching in May, and unsmoked back bacon climbed 22%.
- Nitrite-free bacon spend reached £34.8m in the 52 weeks to 6 September 2026 (up 11.4% year on year) while conventional bacon spend fell 9.2% and volumes dropped 4.9%, per Worldpanel by Numerator data.
- The Food Standards Agency says there is no evidence processed meats made without nitrite additives are safer, and warns that removing nitrites creates food safety challenges since the chemicals help prevent the growth of dangerous bacteria.
- The WHO classifies processed meat as a group 1 carcinogen — the same category as tobacco — though the FSA notes the link to cancer cannot be directly attributed to nitrites and no single component has been identified as the cause; eating roughly 50g of processed meat a day is linked to a 16% higher relative risk of colorectal cancer.
- Nutritionist Gabriela Peacock said nitrite-free products are often pricier due to smaller producers, different curing methods, shorter shelf life, or premium positioning, and cautioned that 'nitrate-free' does not give a product 'a magic health halo.'
Why it matters: Shoppers are paying a premium for nitrite-free bacon based on a perceived health benefit that UK regulators explicitly say is unproven. Tesco and Waitrose are expanding shelf space for a category whose core selling point — safety — the FSA directly disputes, while Denhay's MD concedes the shift is demand-driven, not science-led.
Ask SkimNews
